Dille B J, Johnson T C
J Gen Virol. 1982 Sep;62 (Pt 1):91-103. doi: 10.1099/0022-1317-62-1-91.
Addition of 50 micrograms/ml chloroquine to neuroblastoma cells 1 h before infection with temperature-sensitive mutant ts G31 (III) of vesicular stomatitis virus (VSV) prevented virus-induced cell fusion from occurring. Interestingly, addition of chloroquine after infection still inhibited cell fusion. Based on the number of fusion events required to produce the polykaryocytes observed, cell fusion was inhibited 92% when chloroquine was added 1 h post-infection and 77% when chloroquine was added 2 h post-infection. The inhibition of virus-induced cell fusion could not be accounted for by an inhibition of virus protein synthesis because the virus protein synthesis measured 6 h post-infection was 90% of that in untreated, infected cells with chloroquine added 1 h post-infection, and the same as untreated, infected cells when chloroquine was added 2 h post-infection. No virus proteins were made, however, when chloroquine was added before infection, which is consistent with a chloroquine-mediated inhibition of virus uncoating. The release of infectious virions was completely inhibited when chloroquine was added before infection or 1 or 2 h post-infection, which indicated an inhibition of virus maturation in the later stages of virus assembly. By indirect immunofluorescence the virus glycoprotein (G protein) could not be detected on the surface of chloroquine-treated, infected cells, but the G protein was present inside the treated cells. With 125I-labelled anti-G protein IgG, 16% of the G protein found on the surface of untreated, infected cells was on the cell surface when chloroquine was added 2 h post-infection. When chloroquine was removed from infected cells, the G protein accumulated at the cell surface, and this accumulation could not be prevented by tunicamycin, an inhibitor of glycosylation. Furthermore, galactose was incorporated into the G protein in the presence of chloroquine. Therefore, the VSV G protein was being synthesized and glycosylated in the presence of chloroquine but the drug prevented the expression of the glycoprotein at the cell surface during the final stages of G protein assembly.U
在用对温度敏感的水泡性口炎病毒(VSV)突变体ts G31(III)感染神经母细胞瘤细胞前1小时加入50微克/毫升氯喹,可防止病毒诱导的细胞融合发生。有趣的是,在感染后加入氯喹仍能抑制细胞融合。根据产生观察到的多核细胞所需的融合事件数量,感染后1小时加入氯喹时细胞融合被抑制92%,感染后2小时加入氯喹时细胞融合被抑制77%。病毒诱导的细胞融合受到抑制不能用病毒蛋白合成受抑制来解释,因为感染后6小时测得的病毒蛋白合成量,在感染后1小时加入氯喹的情况下是未处理的感染细胞的90%,在感染后2小时加入氯喹的情况下与未处理的感染细胞相同。然而,在感染前加入氯喹时没有病毒蛋白产生,这与氯喹介导的病毒脱壳抑制作用一致。当在感染前或感染后1或2小时加入氯喹时,感染性病毒粒子的释放被完全抑制,这表明在病毒装配后期病毒成熟受到抑制。通过间接免疫荧光法,在氯喹处理的感染细胞表面检测不到病毒糖蛋白(G蛋白),但G蛋白存在于处理过的细胞内部。用125I标记的抗G蛋白IgG检测,感染后2小时加入氯喹时,在未处理的感染细胞表面发现的G蛋白有16%位于细胞表面。当从感染细胞中去除氯喹时,G蛋白在细胞表面积累,而这种积累不能被糖基化抑制剂衣霉素阻止。此外,在氯喹存在的情况下半乳糖被掺入G蛋白中。因此,VSV G蛋白在氯喹存在的情况下进行合成和糖基化,但该药物在G蛋白装配的最后阶段阻止了糖蛋白在细胞表面的表达。